Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment

Category Primary study
JournalJournal of Clinical Oncology
Year 2020
This article has no abstract
Epistemonikos ID: d6aebd9d87690c73746720b29ac8f7b88ce4954d
First added on: Feb 12, 2025